Research shows which is most sycophantic of the four major AI chatbots, based on responses to Reddit's Am I The A***Hole ...

Our understanding of psychedelics' effects on the brain is expanding rapidly, with over 400 clinical trials currently ...

The Atturra (ASX: ATA) share price has dropped below the Atturra IPO price of $0.50 after pathetic H1 FY 2026 Atturra results ...

As Pentagon policy interpreted as "divorce" from Europe, what is Australia's place in the post-Iran attack security scenario?

I (Growthgauge here) have been following the turnaround of Kip McGrath Education Centres for a couple of years now, and you can find my earlier articles here. Below, I’ve sketched out the turnaround ...

This morning, radiology software company Pro Medicus (ASX: PME) reported its results for the first half of 2024, and in response, the share price has fallen around 11% from $108 to $95.70 at the time ...

Last time I covered the FY25 results here, I indicated that this didn’t seem like a one-year transition. Instead, it felt like a two-to-three-year adjustment period before the business could return to ...

Recently, I was asked to talk about Dubber (ASX: DUB) on Ausbiz. Dubber is one of the worst listed securities in Australia, I never been long or short the stock. Currently, the stock is suspended from ...

Cuscal (ASX: CCL) is the leading payments infrastructure provider in Australia, outside of the major banks. Established in 1966 by a group of credit unions, it has grown from its mutual roots into a ...

This morning, Energy One (ASX: EOL) released its results for H1 FY 2026, reporting revenue growth of 21% to $34.8 million, and net profit after tax growth of 61% to $4m. Over 90% of the revenue is ...

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...